Advertisement

Obesity

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes
Events & Education
Practical Updates in Primary Care

Research Summaries

Research summary
surgical tools
Research summary
Gastric Bypass Surgery Improves Continued Type 2 Diabetes Remission, Even After Weight Recurrence
03/22/2024

Jessica Ganga

Jessica Ganga
Researchers sought to determine whether patients with type 2 diabetes and obesity experience continued type 2 diabetes remission.
03/22/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves Semaglutide For Reducing Serious Cardiovascular Events Among Adults With Heart Disease and Obesity, Overweight
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...
03/21/2024
Research Summary
weightloss medication
Research Summary
Late-Stage Persistence With Anti-Obesity Medication Varies By Medication, Weight Loss At 6 Months
02/14/2024

Jessica Ganga

Jessica Ganga
Researchers evaluated the early- and later-stage use of various anti-obesity medications in patients.
02/14/2024
Research Summary
rs
Research Summary
Semaglutide Provides Benefits for Patients With HFpEF and Obesity
11/22/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.
11/22/2023
FDA Alert
fda
FDA Alert
Tirzepatide Gains FDA Approval for Chronic Weight Management
11/13/2023
Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.
11/13/2023
Research Summary
liver
Research Summary
Guideline Update from the American Diabetes Association for the Detection, Management of Patients With Diabetes, Nonalcoholic Fatty Liver Disease
06/28/2023
Based on recent scientific knowledge, the American Diabetes Association (ADA) released a set of updates including recommendations for the detection and management of nonalcoholic fatty liver disease in...
06/28/2023
Childhood Obesity
Childhood Obesity
New Pediatric Obesity Treatment Guidelines Recommend Early, Intensive Treatment
01/17/2023
After 15 years, the American Academy of Pediatrics has released an updated guideline on the treatment and management of childhood obesity.
01/17/2023
Mediterranean Diet
Mediterranean Diet
Green-Mediterranean Diet Reduces Two Times Amount of Visceral Adipose Tissue Compared to Mediterranean Diet Alone
12/28/2022
The researchers compared the effects of the traditional Mediterranean diet to the green-Mediterranean diet on visceral adipose tissue loss.
12/28/2022
Obesity
Obesity
High Prevalence of NAFLD, NASH in Overweight, Obese Populations
12/05/2022
Researchers identified the prevalence of non-alcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH) in individuals who are overweight or obese. ...
12/05/2022
Conference Coverage
Conference Coverage
New and Emerging Treatments in Managing Type 2 Diabetes, Obesity
11/18/2022
Emerging treatments have improved the standard of care for managing patients with both type 2 diabetes and obesity. Carol Wysham, MD, and Deborah B. Horn, DO, MPH, discuss these new treatments and...
11/18/2022